Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and...
Vous n'êtes pas connecté
A groundbreaking study has shown that a drug currently being tested for ovarian and bile duct cancer, called NXP800, could also help treat advanced prostate cancer that no longer responds to hormone therapy. Published in Clinical Cancer Research, the study highlights how NXP800 slows the growth of prostate cancer cells, even in cases resistant to standard […]
Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and...
In a monumental breakthrough in cancer research, a team of scientists from South Korea has unveiled a revolutionary technology that may turn cancerous...
Keck Medicine of the University of Southern California is participating in a national, multisite clinical trial examining if a water vapour system...
A new study led by University of Arizona Mel and Enid Zuckerman College of Public Health researchers in collaboration with fire service partners and...
The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal of Clinical Oncology...
A study led by scientists at Rutgers University-New Brunswick has shown that specialized cells involved in how the body responds to insulin are...
WEDNESDAY, Jan. 15, 2025 -- There seems to be no association between hormone therapy (HT) and glioma risk among U.S. women, according to a study...
A groundbreaking prostate cancer treatment has returned to WA after a lack of expertise in the State meant men had to travel to access the life-saving...
A groundbreaking study reveals that the drug LL-341070 could help repair myelin damage, offering hope for vision restoration in people with multiple...
A recent analysis has revealed a strong connection between physical strength, fitness, and a longer life for people with cancer. The study, published...